Acute Cardiorenal Syndrome: Models and Heart-Kidney Connectors

Yoshio Funahashi1, Sheuli Chowdhury2, Mahaba B Eiwaz2

  • 1Anesthesiology & Perioperative Medicine, Oregon Health & Science University, Portland, Oregon, USA, funahash@ohsu.edu.

Nephron
|August 20, 2020
PubMed

Insights

Cardiorenal syndrome type 1 (CRS-1), a form of acute kidney injury (AKI) from heart issues, lacks clear mechanisms and treatments. This review explores models and non-flow mediators to advance CRS-1 research.

Area of Science:

  • Nephrology
  • Cardiology
  • Pathophysiology

Background:

  • Cardiorenal syndrome type 1 (CRS-1) involves acute kidney injury (AKI) secondary to acute cardiac dysfunction.
  • AKI affects over 20% of acute heart failure patients, predicting poor prognosis.
  • Current understanding of heart-kidney interaction mechanisms in CRS-1 is limited by research barriers.

Purpose of the Study:

  • To address challenges in investigating CRS-1.
  • To review existing animal and cell-culture models for CRS-1 research.
  • To explore non-flow and endocrine mediators of heart-kidney interaction in CRS-1.

Main Methods:

  • Review of current literature on CRS-1 models and mechanisms.
  • Focus on insights from available animal models.
  • Analysis of non-flow and endocrine mediators, including heart-derived messengers.

Main Results:

  • Significant barriers hinder CRS-1 investigation, including lack of models and biomarkers.
  • Mechanisms of heart-kidney interaction remain unclear.
  • Non-flow and endocrine mediators are potential targets for CRS-1 therapy.

Conclusions:

  • Further development of animal and cell-culture models is crucial for CRS-1 research.
  • Understanding non-flow and endocrine mediators may reveal targetable pathways.
  • Effective therapies for CRS-1 are currently lacking and require further investigation.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
759
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
692
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
488
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
664
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
549
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
177